News & Events about Chimerix Inc.
DURHAM, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will present a ...
Business Wire
2 months ago
Rubric Capital Management LP (Rubric), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (Chimerix or the Company) (NASDAQ: CMRX), today sent a letter to Chimerixs Board of Directors (the Board). In its letter, Rubric...
Globe Newswire
5 months ago
- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDAs Discretion Over 10 Years - Emergent BioSolutions, Inc. Payment Increases to $238M Upfront and $136.5M in Potential Milestones - DURHAM, N.C., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a...
Demand for Comprehensive Cleaning Services Grow Post-Pandemic Demand for Comprehensive Cleaning Services Grow Post-Pandemic PR Newswire NEW YORK, Aug. 26, 2022 FinancialBuzz.com News Commentary NEW YORK, Aug. 26, 2022 /PRNewswire/ -- Due to the growing implementation of AI and automation in...
Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen? Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen? PR Newswire NEW YORK, July 25, 2022 NEW YORK, July 25, 2022 /PRNewswire...